{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:12:54Z","timestamp":1772165574722,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The simultaneous use of drugs with different mechanisms of analgesic action is a strategy for achieving effective pain control while minimizing dose-related side effects. Choline was described to potentiate the analgesic action of parecoxib sodium at small doses in several inflammatory pain models. However, these findings are still very limited, and more associated data are required to confirm the effectiveness of the combined choline and parecoxib sodium therapy against inflammatory pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adult rats were randomly divided into 9 groups (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20096\/group). The sham surgery group received an intraperitoneal (i.p.) injection of saline. Rats with chronic constriction injury (CCI) of the sciatic nerve received saline, choline (cho, 6, 12 and 24\u2009mg\/kg), parecoxib sodium (pare, 3, 6, and 12\u2009mg\/kg), or a combination of choline 6\u2009mg\/kg and parecoxib sodium 3\u2009mg\/kg. Mechanical and heat pain thresholds were measured at 30\u2009min after drug treatment at Days 3, 5, 7, 10, and 14 after CCI. Another 30 rats were divided into 5 groups (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20096\/group): the sham, CCI\u2009+\u2009saline, CCI\u2009+\u2009cho-6\u2009mg\/kg, CCI\u2009+\u2009pare-3\u2009mg\/kg, and CCI\u2009+\u2009cho-6\u2009mg\/kg\u2009+\u2009pare-3\u2009mg\/kg groups. After repeated drug treatment for 7\u2009days, five rats were randomly selected from each group, and the lumbar dorsal root ganglia (DRGs) (L4\u20136) were harvested for western blot analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Choline significantly attenuated mechanical and heat hypersensitivity in CCI rats at 12 and 24\u2009mg\/kg doses (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) but was not effective at the 6\u2009mg\/kg dose. Parecoxib sodium exerted significant pain inhibitory effects at the 6 and 12\u2009mg\/kg doses (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) but not at the 3\u2009mg\/kg dose. Combining a low dose of choline (6\u2009mg\/kg) and parecoxib sodium (3\u2009mg\/kg) produced significant pain inhibition in CCI rats and reduced the expression of high mobility group protein 1 (HMGB1) and nuclear factor-kappa Bp65 (NF-\u03baBp65) in L4\u20136 DRGs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>1. In a rat model of chronic neuropathic pain (CCI), at a certain dose, choline or parecoxib sodium can alleviate mechanical pain and thermal hyperalgesia caused by CCI. 2. The combination of choline and parecoxib sodium in nonanalgesic doses can effectively relieve neuropathic pain, and its mechanism may be related to the inhibition of the high mobility group protein 1 (HMGB1)\/Toll-like receptor 4 (TLR4)\/nuclear factor kappa-B (NF-\u03baB) pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-022-01913-0","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T01:10:35Z","timestamp":1673572235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition effect of choline and parecoxib sodium on chronic constriction nerve injury-induced neuropathic pain in rats"],"prefix":"10.1186","volume":"23","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeguo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"issue":"5","key":"1913_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/ACO.0000000000000766","volume":"32","author":"VS Ban","year":"2019","unstructured":"Ban VS, Bhoja R, McDonagh DL. Multimodal analgesia for craniotomy. Curr Opin Anesthesio. 2019 Oct;32(5):592\u20139.","journal-title":"Curr Opin Anesthesio"},{"issue":"1","key":"1913_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"B Nanna","year":"2021","unstructured":"Nanna B, Rohini K, Troels S. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021;101(1):259\u2013301.","journal-title":"Physiol Rev"},{"key":"1913_CR3","first-page":"8685954","volume":"2019","author":"S D\u00e9lia","year":"2019","unstructured":"D\u00e9lia S, J\u00e1nos T, Aliz N, L\u00e1szl\u00f3 V. Therapeutic approaches for peripheral and central neuropathic pain. Behav Neurol. 2019;2019:8685954.","journal-title":"Behav Neurol"},{"issue":"4","key":"1913_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/papr.12294","volume":"16","author":"HL Chen","year":"2016","unstructured":"Chen HL, Luo AL. Safety and Efficacy Study of the Cyclooxygenase-2 Inhibitor Parecoxib Sodium Applied for Postoperative Analgesia After Endo-Nasal Operation. Pain Pract. 2016;16(4):467\u201372.","journal-title":"Pain Pract"},{"issue":"12","key":"1913_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41593-021-00949-8","volume":"24","author":"K Zhang","year":"2021","unstructured":"Zhang K, F\u00f6rster R, He W, Liao X, Li J, Yang C, et al. Fear learning induces \u03b17-nicotinic acetylcholine receptor-mediated astrocytic responsiveness that is required for memory persistence. Nat Neurosic. 2021;24(12):1686\u201398.","journal-title":"Nat Neurosic"},{"key":"1913_CR6","doi-asserted-by":"publisher","first-page":"107160","DOI":"10.1016\/j.intimp.2020.107160","volume":"90","author":"W Wang","year":"2021","unstructured":"Wang W, Xu H, Lin H, Molnar M, Ren H. The role of the cholinergic anti-inflammatory pathway in septic cardiomyopathy. Int Immunopharmacol. 2021;90:107160.","journal-title":"Int Immunopharmacol"},{"issue":"Suppl 1","key":"1913_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/anae.15256","volume":"76","author":"Y-YK Chen","year":"2021","unstructured":"Chen Y-YK, Boden KA, Schreiber KL. The role of regional anaesthesia and multimodal analgesia in the prevention of chronic postoperative pain: a narrative review. Anaesthesia. 2021;76(Suppl 1):8\u201317.","journal-title":"Anaesthesia"},{"key":"1913_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1517\/14656566.1.2.277","volume":"1","author":"A Bennett","year":"2000","unstructured":"Bennett A, Villa G. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Expert Opin Pharm. 2000;1:277\u201386.","journal-title":"Expert Opin Pharm"},{"issue":"1\u20132","key":"1913_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neurol.2018.09.016","volume":"175","author":"D Bouhassira","year":"2019","unstructured":"Bouhassira D. Neuropathic pain: definition, assessment and epidemiology. Rev Neurol. 2019;175(1\u20132):16\u201325.","journal-title":"Rev Neurol"},{"issue":"1","key":"1913_CR10","first-page":"291","volume":"21","author":"J Wu","year":"2020","unstructured":"Wu J, Wang C, Ding H. LncRNA MALAT1 promotes neuropathic pain progression through the miR-154-5p\/AQP9 axis in CCI rat models. Mol Med Rep. 2020;21(1):291\u2013303.","journal-title":"Mol Med Rep"},{"key":"1913_CR11","first-page":"e928205","volume":"27","author":"F Wu","year":"2021","unstructured":"Wu F, Wang W, Duan Y, Guo J, Li G, Ma T. Effect of Parecoxib sodium on myocardial ischemia-reperfusion injury rats. Med Sci Monit. 2021;27:e928205.","journal-title":"Med Sci Monit"},{"issue":"6","key":"1913_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.29271\/jcpsp.2019.06.528","volume":"29","author":"J Chen","year":"2019","unstructured":"Chen J, Cong X, Zhan X, Zheng Z, Zheng W. Effects of Parecoxib on Pain Threshold and Inflammatory Factors IL-1\u03b2, IL-6 and TNF-\ud835\udf36 in Spinal Cord of Rats with Bone Cancer Pain. J Coll Physicians Surg Pak. 2019;29(6):528\u201331. https:\/\/doi.org\/10.29271\/jcpsp.2019.06.528.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"1913_CR13","doi-asserted-by":"publisher","first-page":"e030501","DOI":"10.1136\/bmjopen-2019-030501","volume":"10","author":"Q Zhuang","year":"2020","unstructured":"Zhuang Q, Tao L, Lin J, Jin J, Qian W, Bian Y, et al. Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial. BMJ Open. 2020;10(1):e030501.","journal-title":"BMJ Open"},{"key":"1913_CR14","doi-asserted-by":"crossref","unstructured":"Sun Y, Xu Q, Wu Z, et al. Parecoxib inhibits inflammatory responses in a mouse model of sepsis. FEBS Open Bio. 2022;12(1):332.","DOI":"10.1002\/2211-5463.12856"},{"issue":"4","key":"1913_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/os.12410","volume":"10","author":"YY Bian","year":"2018","unstructured":"Bian YY, Wang LC, Qian WW, Lin J, Jin J, Peng HM, et al. Role of Parecoxib sodium in the multimodal analgesia after Total knee arthroplasty: a randomized double-blinded controlled trial. Orthop Surg. 2018;10(4):321\u20137.","journal-title":"Orthop Surg"},{"key":"1913_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.05.002","volume":"179","author":"B Donald","year":"2017","unstructured":"Donald B. Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol Therap. 2017;179:1\u201316.","journal-title":"Pharmacol Therap"},{"issue":"22","key":"1913_CR17","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1021\/acs.jmedchem.9b01467","volume":"62","author":"A Gisela","year":"2019","unstructured":"Gisela A, Clare S, Brendan M, Katarzyna K, Stefania B, Lisa D, et al. Synthesis, pharmacological characterization, and structure-activity relationships of noncanonical selective agonists for \u03b17 nAChRs. J Med Chem. 2019;62(22):10376\u201390.","journal-title":"J Med Chem"},{"key":"1913_CR18","doi-asserted-by":"crossref","unstructured":"Lotte S, Nicole J, Michiel G, Rima O, Marc M, Diederik E. Natural choline from egg yolk phospholipids is more efficiently absorbed compared with choline bitartrate; outcomes of a randomized trial in healthy adults. Nutrients. 2019;11(11).","DOI":"10.3390\/nu11112758"},{"issue":"5","key":"1913_CR19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s11064-019-02749-w","volume":"44","author":"R Laleh","year":"2019","unstructured":"Laleh R, Sakineh S, Alizadeh A, Soheila F, Abbas H. Spinal Orexin-2 receptors are involved in modulation of the lateral hypothalamic stimulation-induced analgesia. Neurochem Res. 2019;44(5):1152\u20138.","journal-title":"Neurochem Res"},{"key":"1913_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pbb.2009.01.013","volume":"92","author":"D Minarda","year":"2009","unstructured":"Minarda D, Irene D, Alma R, Adriana M, Francisco J. Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury. Pharmacol Biochem Behav. 2009;92:457\u201364.","journal-title":"Pharmacol Biochem Behav"},{"issue":"92","key":"1913_CR21","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopha.2017.05.099","volume":"3","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Li X, Li Q. Curcumin accelerates the repair of sciatic nerve injury in rats through reducing Schwann cells apoptosis and promoting myelinization. Biomed Pharmacother. 2017;3(92):1103\u201310.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1913_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12974-017-0799-4","volume":"14","author":"G Leon","year":"2017","unstructured":"Leon G, Zou J, Crews F. Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7. J Neuroinflam. 2017;14(1):22.","journal-title":"J Neuroinflam"},{"issue":"1","key":"1913_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12967-019-1900-9","volume":"17","author":"Y Tao","year":"2019","unstructured":"Tao Y, Wang M, Wu D, Luo C, Tang H, Chen E. Apolipoprotein A5 alleviates LPS\/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-\u03baB pathway. J Trans Med. 2019;17(1):151.","journal-title":"J Trans Med"},{"key":"1913_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2019.03.016","volume":"1715","author":"J Liu","year":"2019","unstructured":"Liu J, Chen Y, Wei H, Chang R, Yu D, Wang X, et al. Activation of alpha7 acetylcholine receptors reduces neuropathic pain by decreasing dynorphin a release from microglia. Brain Res. 2019;1715:57\u201365.","journal-title":"Brain Res"},{"issue":"12","key":"1913_CR25","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1097\/j.pain.0000000000002027","volume":"161","author":"G Kimberly","year":"2020","unstructured":"Kimberly G, Tissiana G, Aubin M, Samantha PM, Rodolfo D, Ricardo F, et al. The role of cyclin-dependent kinase 5 in neuropathic pain. Pain. 2020;161(12):2674\u201389.","journal-title":"Pain"},{"issue":"1","key":"1913_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-017-0917-3","volume":"14","author":"X Chen","year":"2017","unstructured":"Chen X, Wu S, Chen C, Xie B, Fang Z, Hu W, et al. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1\/TLR4\/NF-\u03baB pathway following experimental traumatic brain injury. J neuroinflam. 2017;14(1):143.","journal-title":"J neuroinflam"},{"issue":"4","key":"1913_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000500920","volume":"44","author":"J Jonas","year":"2019","unstructured":"Jonas J, Benito Y. Simone H; the cholinergic anti-inflammatory pathway as a conceptual framework to treat inflammation-mediated renal injury. Kidney Blood Pressure Res. 2019;44(4):435\u201348.","journal-title":"Kidney Blood Pressure Res"},{"issue":"21","key":"1913_CR28","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1021\/acschemneuro.0c00476","volume":"11","author":"R Hugo","year":"2020","unstructured":"Hugo R, Carla G, Elena L, Han T, Arsalan Y, Irina M, et al. (E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its derivative DM489 decrease neuropathic pain in mice predominantly by \u03b17 nicotinic acetylcholine receptor potentiation. ACS Cheml Neurosci. 2020;11(21):3603\u201314.","journal-title":"ACS Cheml Neurosci"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01913-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01913-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01913-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T01:10:56Z","timestamp":1673572256000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01913-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01913-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1385762\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Care and Use Committee of Chinese PLA General Hospital on 16 February 2021 (Ethics approval ID: 20210216\u2013001) and was performed according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The study was carried out in compliance with the ARRIVE guidelines..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all the participants to publish the information\/image(s) in an online open-access publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no conflicts of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}